CVE:PAS Pascal Biosciences (PAS) Stock Price, News & Analysis → Seven unknown AI stocks that could DOMINATE the next six years. (From The Oxford Club) (Ad) Free PAS Stock Alerts C$0.02 -0.01 (-25.00%) (As of 12/5/2022) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.02▼C$0.10Volume4,000 shsAverage Volume52,289 shsMarket CapitalizationC$983,850.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Pascal Biosciences alerts: Email Address Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! About Pascal Biosciences Stock (CVE:PAS)Pascal Biosciences Inc., a biotechnology company, engages in the research and development of products for the treatment of cancer, and for the improvement of the immune system. The company's development portfolio includes PAS-403, a mitosis inhibitor that blocks cell division for the treatment of glioblastoma and brain metastases originating from other cancers; and PAS-393, an immune-stimulatory cannabinoid designed to restore the immunogenicity of tumor cells with checkpoint inhibitor therapy for use in cancer treatment. It is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic products for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was incorporated in 2011 and is headquartered in Seattle, Washington.Read More PAS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PAS Stock News HeadlinesMay 23 at 12:30 AM | nytimes.comBrighton’s player of the season: Pascal Gross, the assist machineMay 22 at 7:30 PM | sportsbookwire.usatoday.comPascal Siakam Player Prop Bets: Pacers vs. Knicks | May 19May 22 at 7:30 PM | msn.com“Pedro Pascal doesn’t look 61 there”: HBO May Go Against The Last of Us Video Game to Make a Crucial Change in Season 2 That Will Make It Even More HeartbreakingMay 22 at 7:30 PM | msn.comPedro Pascal Finds Paradise in Outrageous Corona Ad Directed by Craig Gillespie – WatchMay 22 at 2:30 PM | msn.comForget Beskar, Pedro Pascal’s Upcoming The Mandalorian & Grogu Film Can Introduce a Legendary Weapon That Cancels LightsabersMay 22 at 2:30 PM | yahoo.comPedro Pascal on Collaborating With Omar Apollo, Making Materialists With Celine Song, and Getting “A Little Drunk” at the SAG AwardsMay 22 at 2:30 PM | finance.yahoo.comCorona® Unveils Refreshed “La Vida Más Fina™” Campaign Starring Pedro PascalMay 22 at 9:29 AM | msn.comPedro Pascal Highlights What His Perfect Summer Day Looks Like: 'I Love the Beach' (Exclusive)May 22 at 1:14 AM | msn.comHow Did Pascal Stay Inbounds?!May 21 at 12:06 AM | msn.comPedro Pascal Revealed Din Djarin's Character Arc Five Years Ago - But Where Does It Go Next?May 20 at 3:54 AM | sportsbookwire.usatoday.comPascal Siakam Player Prop Bets: Pacers vs. Celtics | May 21May 18, 2024 | msn.comPascal Siakam, Myles Turner lead Pacers to win over Knicks, force Game 7May 18, 2024 | msn.comTyrese Haliburton, Pascal Siakam warn Pacers of what awaits in Game 7 vs. KnicksMay 18, 2024 | msn.comKnicks have no answers for Pacers’ Pascal Siakam in Game 6 lossMay 17, 2024 | msn.com‘The Last of Us’ Season 2 First Look: Pedro Pascal and Bella Ramsey Continue to Endure the ApocalypseMay 16, 2024 | msn.comOmar Apollo fans think he wrote a song about Pedro PascalMay 16, 2024 | msn.comOmar Apollo’s New Album God Said No Will Feature Pedro PascalMay 16, 2024 | msn.comAI-generated images of Pascal Donohoe used to show dangers of identity fraud during anti-financial crime summitMay 16, 2024 | yahoo.comPedro Pascal is still our post-apocalyptic daddy in teaser pics from 'The Last of Us' season 2May 16, 2024 | msn.comPedro Pedro Pascal, Bella Ramsey return in The Last of Us Season 2 first lookMay 16, 2024 | sportsbookwire.usatoday.comPascal Siakam Player Prop Bets: Pacers vs. Knicks | May 17May 15, 2024 | msn.com‘The Last of Us’: HBO Unveils First Look at Pedro Pascal & Bella Ramsey in Season 2 (PHOTOS)May 15, 2024 | msn.com“The Last of Us: ”Pedro Pascal, Bella Ramsey Are Ready for Show's Next Big Adventure in Season 2 First LookMay 15, 2024 | yahoo.comThe Last of Us season 2 gets first look at Pedro Pascal and Bella RamseyMay 15, 2024 | msn.comPedro Pascal is back! Check out new photos of ‘The Last of Us’ season 2See More Headlines Receive PAS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pascal Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:PAS CUSIPN/A CIKN/A Webwww.biommune.net Phone+1-604-6886775FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-340.40% Debt Debt-to-Equity Ratio882.79 Current Ratio0.03 Quick Ratio0.17 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow55.00 Book ValueC($0.02) per share Price / Book-0.75Miscellaneous Outstanding Shares65,590,000Free FloatN/AMarket CapC$983,850.00 OptionableNot Optionable Beta1.51 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Harold H. Forzley C.A. (Age 69)Chief Financial Officer Comp: $16.8kDr. Brian W. Bapty Ph.D. (Age 53)CEO, Pres & Director Mr. Kevin M. Egan M.B.A.Chief Bus. OfficerKey CompetitorsiCo TherapeuticsCVE:ICOCotinga Pharmaceuticals Inc. (COT.V)CVE:COTSolarvest BioEnergyCVE:SVSBioasis TechnologiesCVE:BTIMedifocus Inc. (MFS.V)CVE:MFSView All Competitors PAS Stock Analysis - Frequently Asked Questions How have PAS shares performed in 2024? Pascal Biosciences' stock was trading at C$0.02 on January 1st, 2024. Since then, PAS stock has increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. What other stocks do shareholders of Pascal Biosciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pascal Biosciences investors own include Aurora Cannabis (ACB), Canadian Natural Resources (CNQ), Corus Entertainment (CJR), Auxly Cannabis Group (CBWTF), Grande West Transportation Group (BUS), Bausch Health Companies (BHC), Abattis Bioceuticals (ATT), Algonquin Power & Utilities (AQN), Aphria (APHA) and Abacus Mining & Exploration (AME). How do I buy shares of Pascal Biosciences? Shares of PAS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:PAS) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersTruth about Trump you’ve never heardPorter & CompanyThis could mean the end of the U.S dollar…Colonial MetalsThe 1,000X Crypto PlaybookTrue Market InsidersGold Set to EXPLODE!Gold Safe Exchange[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyAlex’s “Next Magnificent Seven” stocksThe Oxford ClubNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pascal Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.